BioPharma Credit PLC - life sciences debt investment trust - Reports Lexicon Pharmaceuticals repays USD150 million secured loan in full, of which BioPharma was owed USD124.5 million. BioPharma receives principal amount of outstanding USD124.5 million plus US2.2 million interest and USD5.6 million prepayment fees.
Current stock price: USD1.02
Year-to-date change: flat
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
Biopharma Cred. (BPCR)